These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12894159)

  • 1. Anthrax delivers a lethal blow to host immunity.
    Starnbach MN; Collier RJ
    Nat Med; 2003 Aug; 9(8):996-7. PubMed ID: 12894159
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes.
    Ingram RJ; Metan G; Maillere B; Doganay M; Ozkul Y; Kim LU; Baillie L; Dyson H; Williamson ED; Chu KK; Ascough S; Moore S; Huwar TB; Robinson JH; Sriskandan S; Altmann DM
    J Immunol; 2010 Apr; 184(7):3814-21. PubMed ID: 20208010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for improved anthrax vaccines.
    Brey RN
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax toxins: A paradigm of bacterial immune suppression.
    Baldari CT; Tonello F; Paccani SR; Montecucco C
    Trends Immunol; 2006 Sep; 27(9):434-40. PubMed ID: 16861036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin.
    Agrawal A; Lingappa J; Leppla SH; Agrawal S; Jabbar A; Quinn C; Pulendran B
    Nature; 2003 Jul; 424(6946):329-34. PubMed ID: 12867985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.
    Fukao T
    Lancet Infect Dis; 2004 Mar; 4(3):166-70. PubMed ID: 14998502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax toxins: a weapon to systematically dismantle the host immune defenses.
    Tournier JN; Rossi Paccani S; Quesnel-Hellmann A; Baldari CT
    Mol Aspects Med; 2009 Dec; 30(6):456-66. PubMed ID: 19560486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
    Xu L; Frucht DM
    Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of anthrax toxin in pathogenesis.
    Moayeri M; Leppla SH
    Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthrax. 'Borrowed immunity' may save future victims.
    Enserink M
    Science; 2002 Feb; 295(5556):777. PubMed ID: 11823609
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
    J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anthrax revisited: Bacillus anthracis toxins as novel actors of immune escape?].
    Tournier JN; Quesnel-Hellmann A; Cleret A; Mathieu J; Goossens PL; Mock M; Vidal DR
    Bull Acad Natl Med; 2006 Jan; 190(1):155-63; discussion 163-7. PubMed ID: 16878452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiology. A binding contract for anthrax.
    Bull JJ; Parrish CR
    Science; 2002 Jul; 297(5579):201-2. PubMed ID: 12114612
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
    Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.